Interstitial Cystitis: Clinical Trials

12 trials for Interstitial Cystitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 2 recruiting, 2 terminated. 12 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 312Completed 5, Unknown 3, Recruiting 2, Terminated 2
Phase 22Recruiting 1, Unknown 1

Follow Interstitial Cystitis: new trials by email Literature Review of Interstitial Cystitis trials Research Report on Interstitial Cystitis

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
Clarix Flo, Placebo - Interstitial Cystitis, Painful Bladder Syndrome
Phase 2 / Phase 3RecruitingDavid Sheyn1002024-07-242026-09-04
Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis
Interferon, Sodium Hyaluronate, Sodium Chloride Injection - Interstitial Cystitis
Phase 2 / Phase 3UnknownWest China Hospital1292023-10-152023-09-15
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
Immunonutrition - Bladder Cancer, Interstitial Cystitis
Phase 3RecruitingCentre Hospitalier Universitaire Vaudois2322023-04-102025-12-09
A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain
Multimodal Bundle Drugs, Operative Cystoscopy, Behavioral health consultation/therapy - Interstitial Cystitis, Levator Spasm
Phase 3TerminatedJocelyn Fitzgerald262022-12-062026-04-01
Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome
Intravesical injection of Platlet Rich Plasma (PRP) - Painful Bladder Syndrome (PBS), Interstitial Cystitis
Phase 3CompletedAin Shams University302021-04-012024-01-17
Clinical Trial Comparing Two Bladder Instillations for IC/BPS
Bladder instillation WITH triamcinolone acetonide, Bladder instillation WITHOUT triamcinolone acetonide - Interstitial Cystitis, Bladder Pain Syndrome
Phase 3CompletedOlivia Cardenas-Trowers, M.D.902019-01-252021-09-01
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
AQX-1125 100 mg, AQX-1125 200 mg, Placebo - Interstitial Cystitis, Bladder Pain Syndrome
Phase 3UnknownAquinox Pharmaceuticals (Canada) Inc.4332016-07-012018-03-15
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
Adalimumab, inactive drug - Interstitial Cystitis
Phase 3CompletedICStudy, LLC432011-03-012015-07-16
Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome
omalizumab - Interstitial Cystitis, Painful Bladder Syndrome
Phase 3CompletedFondazione IRCCS Policlinico San Matteo di Pavia32009-03-012011-02-14
A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . .
Mycophenolate Mofetil, Mycofenolate Mofetil (MMF), Placebo - Interstitial Cystitis, Painful Bladder Syndrome
Phase 3TerminatedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2102007-03-012010-01-14
Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)
Amitriptyline, Placebo - Bladder Diseases, Interstitial Cystitis
Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2712005-02-012026-01-12
Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms
Acupuncture - Interstitial Cystitis
Phase 3UnknownThe Mary Elizabeth Groff Surgical Medical Research and Education Charitable Trust602004-09-012005-06-24

Narrower conditions

Cystitis, Interstitial (12)  ·  Pelvic Pain (2)  ·  Urinary Bladder Diseases (2)  ·  Cystitis, Hemorrhagic (1)  ·  Endometriosis (1)  ·  Inflammation (1)  ·  Malnutrition (1)  ·  Nocturia (1)  ·  Urinary Bladder Neoplasms (1)  ·  Urinary Bladder, Neurogenic (1)

Broader conditions

Cystitis (12)  ·  Female Urogenital Diseases (12)  ·  Female Urogenital Diseases and Pregnancy Complications (12)  ·  Male Urogenital Diseases (12)  ·  Urogenital Diseases (12)  ·  Urologic Diseases (12)  ·  Urinary Bladder Diseases (10)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Neurologic Manifestations (3)  ·  Signs and Symptoms (3)  ·  Pain (2)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Neoplasms (1)

Interventions

Administration, Intravesical (2)  ·  Amitriptyline (2)  ·  4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol (1)  ·  Acupuncture Therapy (1)  ·  Adalimumab (1)  ·  Gabapentin (1)  ·  Hyaluronic Acid (1)  ·  Immunonutrition Diet (1)  ·  Interferons (1)  ·  Methenamine (1)  ·  Mycophenolic Acid (1)  ·  Omalizumab (1)  ·  Sodium Chloride (1)  ·  Therapeutics (1)  ·  Triamcinolone Acetonide (1)

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  Ain Shams University (1)  ·  Aquinox Pharmaceuticals (Canada) Inc. (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  David Sheyn (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  ICStudy, LLC (1)  ·  Jocelyn Fitzgerald (1)  ·  Olivia Cardenas-Trowers, M.D. (1)  ·  The Mary Elizabeth Groff Surgical Medical Research and Education Charitable Trust (1)  ·  West China Hospital (1)

Countries

United States (8)  ·  Canada (3)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Hungary (1)  ·  Italy (1)  ·  Latvia (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Romania (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Ahmed T Hassan, Assisstant Professor (1)  ·  Daniele Porru, MD (1)  ·  David Burks, MD (1)  ·  David Sheyn, MD (1)  ·  Harris Foster, MD (1)  ·  Jocelyn J Fitzgerald, MD (1)  ·  John Kusek, PhD (1)  ·  LeRoy Nyberg, MD, PhD (1)  ·  Leroy M. Nyberg, Jr., Ph.D, M.D. (1)  ·  Olivia Cardenas-Trowers, M.D. (1)  ·  Philip C Bosch, MD (1)  ·  Richard Landis, PhD (1)  ·  Robert Moldwin, MD (1)  ·  Sean Francis, M.D. (1)  ·  Wei-min Li (1)

Results publications

PMID 32734597, PMID 20303115, PMID 23792149, PMID 33831942, PMID 38587846, PMID 39415282

NIH funding

U01DK065209 (1)